N-acetyltransferase 10 as a novel prognostic biomarker in papillary renal cell carcinoma: a machine learning and experimental validation study

Liyang Li, Fan Li, Chenghao Zhou, Kangxin Ni, Haiyi Hu, Mingchao Wang, Huan Wang, Lei Gao · 2024

Read N-acetyltransferase 10 as a novel prognostic biomarker in papillary renal cell carcinoma: a machine learning and experimental validation study by Liyang Li, Fan Li, Chenghao Zhou, Kangxin Ni, Haiyi Hu, Mingchao Wang, Huan Wang, Lei Gao (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11651807.txt.

Description

Liyang Li and co-authors test an RNA-editing enzyme as a prognosis marker in a kidney cancer subtype, in a study from two thousand twenty-four. The enzyme, NAT10, tags RNA in a way now linked to several cancers. Its role in papillary kidney cancer was unclear.

Data from large cancer atlases showed the enzyme raised across many cancers, with high levels tied to later stage and worse outlook. Single-cell data placed it in the malignant cells themselves. A risk model built from eighteen linked genes forecast survival well in training and outside checks. Lab tests confirmed the enzyme's high levels in tumor tissue.

Catalog record

CREATORLiyang Li, Fan Li, Chenghao Zhou, Kangxin Ni, Haiyi Hu, Mingchao Wang, Huan Wang, Lei Gao
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11651807

Browse the full library · About the Tower of Babel